FORA G20 Comfort Blood Glucose Test Strip Instruction Manual
- June 5, 2024
- FORA
Table of Contents
COMFORT
Blood Glucose Test Strip
312-4308100-012
ver 5.0 2022/06
Warnings
► For in vitro diagnostic use (for use outside of the body only).
► For single use only.
► Healthcare professionals and other users testing multiple patients with this
system should handle everything that has comes into contact with human blood
carefully to prevent transmitting infectious diseases, including sanitized
objects.
► Please read this sheet and your Blood Glucose Monitoring System Owner’s
Manual before you use this test strip. Use only FORA COMFORT Test Strips with
FORA
COMFORT Blood Glucose Monitoring System to obtain accurate results, and be
covered by the manufacturer’s warranty.
► Results may be inaccurate when testing on patients with abnormally low blood
pressure or those who are in shock.
► Please do not use FORA Comfort Blood Glucose Monitoring System on critically
ill patients. While the blood glucose result is extremely hyperglycemia (over
600 mg/dL
(33.3 mmol/L)), the collection of capillary blood from the approved sample
sites is not advised when the peripheral circulation is impaired as the
delivery of physiological blood glucose level might not be a true reflection.
The following circumstances may apply: severe dehydration as a result of
diabetic ketoacidosis or due to stress
hyperglycemic, hyperosmolar non-ketotic coma, shock, decompensated heart
failure NYHA Class IV or peripheral arterial occlusive disease.
► Keep test strips and lancets away from small children. If swallowed, consult
a doctor immediately for advice.
► Patients undergoing oxygen therapy may yield falsely low results. Please
consult a doctor for advice if there are any concerns.
Intended Use
FORA COMFORT test strips, when used together with FORA COMFORT Blood Glucose Monitoring System, allow your blood glucose levels to be measured by yourself at home or by healthcare professionals. It uses fresh whole blood samples from the finger, and the following areas: the palm, forearm and upper arm. This system is not intended for use in the diagnosis or screening of diabetes mellitus. Use only heparin for anticoagulation of whole blood. Please do NOT use EDTA for anticoagulation.
Limitations
- Hematocrit: The hematocrit level is limited to between 20% and 60%. Please ask your healthcare professional if you do not know your hematocrit level.
- Neonatal Use: This test strip must not be used for the testing of newborns.
- Please see Appendix: Summary of substances and concentrations in excess of limitation with interference.
- Altitude Effects: Altitudes up to 10,742 feet (3,275 m) do not affect test results.
- Do not test blood glucose during or soon after a xylose absorption test. Xylose in the blood can produce elevated glucose results.
Storage and Handling
IMPORTANT: Do not use the test strips if they have expired.
► Test strips expire 6 months after first opening. Write the first opening
date on the test strip vial when you first opened it.
► Store the test strips in a cool, dry place between 4°C and 40°C (39.2°F and
104°F) and below 85% relative humidity.
► Keep the test strips away from direct sunlight. Do not store the test strips
in high humidity.
► Store the test strips in their original vial ONLY. Do not transfer them to a
new vial or any other containers.
► Do not touch the test strips with wet hands.
► Use each test strip immediately after taking it out of the vial. Close the
vial immediately after taking out a strip.
► Keep the vial closed at all times.
► Do not bend, cut, or alter the test strip.
**Testing Your Blood Glucose
**
PLEASE WASH AND DRY YOUR HANDS BEFORE PERFORMING ANY TESTS.
Please refer to your Owner’s Manual for more information.
The used lancet and test strip are potentially biohazardous. Please dispose of
them carefully according to your local regulations.
Reading Your Result
Your blood glucose readings deliver plasma equivalent results and are displayed in mg/dL or mmol/L.
Time of day | Normal plasma glucose range for people without diabetes |
---|---|
Fasting and before meal | < 100 mg/dL (5.6 mmol/L) |
2 hours after meals | < 140 mg/dL (7.8 mmol/L) |
Source: American Diabetes Association (2012). Clinical Practice
Recommendations.
Diabetes Care, 35 (Supplement 1): S1-100.
Please consult your doctor to determine a target range that works best for
you.
Questionable or inconsistent results
If your test results are unusual or inconsistent with how you are feeling:
- Make sure the confirmation window of the test strip is completely filled with blood.
- Check the expiry date of the test strips.
- Check the performance of your meter and test strip with the control solutions.
Please Note: Unusually high or low blood glucose levels may be symptoms of a
serious medical condition. If most of your results are unusually high or low,
please contact your
healthcare professional.
Quality Control Testing
Our control solutions contain a known amount of glucose that can react with
test strips. You can check the performance of the meter, test strip and your
technique by comparing the control solution results with the range printed on
the label of test strip vial. Checking regularly can ensure your test results
are accurate. Please refer to the Owner’s Manual for complete testing
instructions.
IMPORTANT: The reference range of the control solutions may vary with
each new test strip. Make sure you check the range on the label of vial or
individual foil pack of your current test strip.
Chemical Components
Glucose oxidase (A. niger) 13%
Electron shuttle 39%
Enzyme protector 6%
Non-reactive ingredients 42%
Additional Information for Healthcare Professionals
Always wear gloves and follow your facility’s biohazard control policy and
procedures when performing tests involving patient blood samples. Use fresh
whole blood samples
only.
Sample Size: 0.5 μL
Reaction Time: 5 seconds
System Measurement Range: 20 mg/dL to 600 mg/dL
Hematocrit Range: 20 % to 60 %
Accuracy
The table below displays how often FORA COMFORT achieves this target. The
chart is based on a study carried out on 160 patients (each patient was tested
six times which
had 960 test results) to see how well FORA COMFORT performed compared to
YSI-2300 reference method results.
Table 1 Accuracy results for glucose concentration < 100 mg/dL (5.55 mmol/L)
Within ±5 mg/dL
(Within ±0.28 mmol/L)| Within ±10 mg/dL
(Within ±0.55 mmol/L)| Within ±15 mg/dL*
(Within ± 0.83 mmol/L)
---|---|---
57.3% (165/288)| 90.3% (260/288)| 100% (288/288)
Table 2 Accuracy results for glucose concentration≧100 mg/dL (5.55 mmol/L)
Within ±5 % | Within ±10 % | Within ±15 %* |
---|---|---|
45.7% (307/672) | 77.8% (523/672) | 95.4% (641/672) |
Table 3 Accuracy results for glucose concentrations between 32.3mg/dL (1.79mmol/L ) to 544.0mg/dL (30.22mmol/L)
Within ±15 mg/dL or ±15% (Within ±0.83 mmol/L or ±15%)
96.8% (929/960)
Note: *According to the accuracy criteria of EN ISO 15197: 2015, 95% of all differences in glucose values (i.e., YSI-2300 reference values minus glucose values of FORA COMFORT) should be within ±15 mg/dL (0.83 mmol/L) for glucose concentration < 100 mg/dL (5.55 mmol/L), and within ±15% for glucose concentration ≥ 100 mg/dL (5.55 mmol/L). When Test Strips results are compared to the reference values, difference values below 100 mg/dL (5.55 mmol/L) are expressed in mg/dL or mmol/L, while those above 100 mg/dL (5.55 mmol/L) in percentage.
User performance
160 subjects were tested with blood samples taken from the fingertip and the
alternative sites, the palm, the forearm and the upper arm. The tables show
how well FORA COMFORT performed compared to YSI-2300 reference method results.
Table 1 Difference distribution for glucose concentration < 100 mg/dL (5.55
mmol/L)
Tested sites| Difference within
±5mg/dL| Difference within
±10mg/dL| Difference within
±15mg/dL
---|---|---|---
Fingertip| 29/46 (63.0%)| 41/46 (89.12%)| 46/46 (100%)
Palm| 23/57 (40.4%)| 46/57 (80.7%)| 57/57 (100%)
Forearm| 13/57 (22.8%)| 44/57 (77.2%)| 57/57 (100%)
Upper arm| 17/57 (29.8%)| 48/57 (84.2%)| 57/57 (100%)
Table 2 Difference distribution for glucose concentration ≥ 100 mg/dL (5.55 mmol/L)
Tested sites| Difference within
±5 %| Difference within
±10 %| Difference within
±15 %
---|---|---|---
Fingertip| 39/114 (34.2%)| 80/114 (70.2%)| 110/114 (96.5%)
Palm| 36/103 (35.0%)| 73/103 (70.9%)| 102/103 (99.0%)
Forearm| 24/103 (23.3%)| 70/103 (68.0%)| 100/103 (97.1%)
Upper arm| 22/103 (21.4%)| 61/103 (59.2%)| 98/103 (95.1%)
Precision
In both intermediate precision and repeatability tests, the standard deviation
(SD) is within 5 mg/dL (0.28 mmol/L) for each glucose concentration < 100
mg/dL (5.55
mmol/L) and the coefficient of variation (CV) is less than 5% for each glucose
concentration ≥ 100 mg/dL (5.55 mmol/L).
For self-testing
**REF**
ACS042
Use only with FORA COMFORT plus G30 / advance G31 / plus mini G71 / plus voice
V30 Blood Glucose Monitoring System/ DUO ultima D40 Blood Glucose Plus Blood
Pressure Monitoring System
Table A The test strip has no interference with the following substances
within and beyond the therapeutic or physiologic concentration range.
Substance| Therapeutic / Physiologic
Concentration Range
(or Upper Limit) (mg/dL)| Concentration Tested
(mg/dL)
---|---|---
Bilirubin (Unconjugated)| 0.2-0.8| 20
Salicylic Acid| 0.952| 60
Cholesterol| <200| 500
Creatinine| 0.72-1.18 men (ID-MS)
0.55-1.02 women (ID-MS)| 30
Gentisic Acid| 0.5| 2
Heparin (Li)| 110 U/dL| 1700 U/dL
Heparin (Na)| 110 U/dL| 1700 U/dL
K2EDTA| 180| 720
K3EDTA| 176.| 702
Ibuprofen| 7.| 55
Icodextrin| 1200| 2000
Maltose| 120| 1000
Tolbutamide| 18.| 64
Xylose| N/A| 1000
Table B The test strip has no interference with the following substances within the therapeutic or physiological concentration range.
Substance| Limiting Concentration
(mg/dL)| Therapeutic / Physiologic Concentration Range (or Upper Limit )
(mg/dL)
---|---|---
Acetaminophen (Paracetamol)| > 6.25| 5.
Ascorbic acid| > 5.0| 2.
Dopamine| > 1.25| 0.0207
Galactose| > 250| < 5
Hemoglobin (Hemolysis Method)| > 100| <3 (plasma)
Levo – Dopa| > 1.4| 0.25
Methyl – Dopa| > 1.25| 0.75
Tolazamide| > 12.5| 2.
Uric acid| > 10| 3.5-7.2
Lipemic Samples (Triglycerides)| > 3000| <150
Table C Summary of anticoagulants and concentrations with interference.
Substance| Limiting
Concentration (mg/dL)| Concentration of
Blood Drawing Tube (mg/dL)
---|---|---
Na-Fluoride/K-Oxalate| < 250/200| 250/200
Table D The following compounds within the therapeutic or physiologic concentration range may produce elevated glucose results.
Substance| Concentration Tested (mg/dL)| Therapeutic / Physiologic
Concentration Range
(or Upper Limit ) (mg/dL)
---|---|---
Pralidoxime Iodide| > 5.0| ~ 10 (i.v. Dose 500 mg)
Reduced Glutathione| > 0.98 mmol/L| 1.88 – 2.58 mmol/L (RBC)
Reference
- Clinical and Laboratory Standards Institute (CLSI). Interference Testing in Clinical Chemistry. 3rd ed. CLSI guideline EP07, 2018.
- Clinical and Laboratory Standards Institute (CLSI). Supplemental Tables for Interference Testing in Clinical Chemistry. 1st ed. CLSI supplement EP37, 2018.
- McEnroe, J Robert, et al. National Committee for Clinical Laboratory Standards. Interference testing in clinical chemistry; Approved Guideline – 2nd edition. NCCLS : 2005 – EP7-A2, volume 25, number 27.
- EN ISO 15197: 2015 (E): In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus, Second edition, section 6.4.4 Interference Testing.
- Hardman JG, Limbird LE, Molinoff PB, et al. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996: 1570-1571.
- Zaloga GP, Macgregor D. The Critical Care Drug Handbook. 2nd ed. St Louis, MO: Mosby-Year Book; 1997.
- Kost GJ, Vu HT, Lee JH, et al. Multicenter study of oxygen-intensive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med. 1998;26:581-590.
Appendix
Symbol | Referent |
---|---|
• In vitro diagnostic medical device | |
• Do not reuse | |
• Consult instructions for use | |
• Temperature limitation | |
• Use by | |
• Keep Dry | |
• Keep away from sunlight | |
• CE mark | |
• Batch code | |
• Humidity limitation | |
• Do not use if package is damaged | |
• 6 months remain after first open | |
• Manufacturer | |
• Model No. | |
• Quantity | |
• Authorised representative in the European Union | |
**UDI** |
• Unique Device Identification |
• Importer | |
• Distribtor |
ForaCare Suisse AG
Neugasse 55, 9000 St. Gallen, Switzerland
www.foracare.ch
MedNet EC-REP GmbH
Borkstraβe 10, 48163, Mϋnster, Germany
Documents / Resources
| FORA
G20 Comfort Blood Glucose Test
Strip
[pdf] Instruction Manual
TD-4308A, G20, Comfort, Blood Glucose Test Strip, Comfort Blood Glucose Test
Strip, G20 Comfort Blood Glucose Test Strip
---|---
References
Read User Manual Online (PDF format)
Read User Manual Online (PDF format) >>